Monday, June 24, 2024

🌎 Church & Dwight Initiated, Anheuser-Busch InBev SA/NV Upgraded, Cinemark Upgraded and more...

Ratings changes for Sirius XM, Sirius XM, Affirm, PayPal, argenx, Cognizant Technology Solutions, Micron Technology and more...From The Oxford Club (Ad): AI's Next Magnificent Seven
June 24th, 2024
S and P pricesDow pricesQQQ prices
Follow MarketBeat on Twitter Join the MarketBeat Facebook Group Subscribe on YouTube 


Your Watchlist (Manage Your Watchlist and Monitor Your Portfolio)

Analysts' Upgrades
  • Anheuser-Busch InBev SA/NV (NYSE:BUD) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.The current price is $60.85.
  • Carrier Global (NYSE:CARR) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $74.00 price target on the stock, up previously from $65.00. This represents a 14.2% upside from the current price of $64.79.
  • Cinemark (NYSE:CNK) was upgraded by analysts at Roth Mkm from a "neutral" rating to a "buy" rating. They now have a $26.00 price target on the stock, up previously from $19.00. This represents a 27.9% upside from the current price of $20.33.
  • Digimarc (NASDAQ:DMRC) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $40.00 price target on the stock. This represents a 38.6% upside from the current price of $28.87.
  • ICF International (NASDAQ:ICFI) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.The current price is $146.73.
  • Planet Fitness (NYSE:PLNT) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating. They now have a $92.00 price target on the stock, up previously from $66.00. This represents a 24.7% upside from the current price of $73.79.
  • Sirius XM (NASDAQ:SIRI) was upgraded by analysts at Evercore ISI from an "underperform" rating to an "in-line" rating. They now have a $3.25 price target on the stock, down previously from $4.25. This represents a 20.8% upside from the current price of $2.69.
  • Solid Biosciences (NASDAQ:SLDB) was upgraded by analysts at SVB Leerink LLC from a "market perform" rating to an "outperform" rating. They now have a $12.00 price target on the stock. This represents a 81.3% upside from the current price of $6.62.
  • Synovus Financial (NYSE:SNV) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $46.00 price target on the stock, up previously from $39.00. This represents a 18.8% upside from the current price of $38.71.
  • View today's most recent analysts' upgrades at MarketBeat.com right arrow


Analysts' Downgrades


Analysts' New Coverage
  • Accenture (NYSE:ACN) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $335.00 price target on the stock. This represents a 7.9% upside from the current price of $310.48.
  • Atlas Energy Solutions (NYSE:AESI) is now covered by analysts at Tudor, Pickering, Holt & Co.. They set a "buy" rating on the stock.The current price is $19.72.
  • Agilysys (NASDAQ:AGYS) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $98.64.
  • Ally Financial (NYSE:ALLY) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $50.00 price target on the stock. This represents a 22.2% upside from the current price of $40.92.
  • Bridger Aerospace Group (NASDAQ:BAER) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $5.50 price target on the stock. This represents a 32.9% upside from the current price of $4.14.
  • Bridger Aerospace Group (NASDAQ:BAER) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $5.50 price target on the stock. This represents a 32.9% upside from the current price of $4.14.
  • Celsius (NASDAQ:CELH) is now covered by analysts at BNP Paribas. They set an "outperform" rating and a $87.00 price target on the stock. This represents a 40.9% upside from the current price of $61.76.
  • Church & Dwight (NYSE:CHD) is now covered by analysts at BNP Paribas. They set a "neutral" rating and a $114.00 price target on the stock. This represents a 5.9% upside from the current price of $107.64.
  • Colgate-Palmolive (NYSE:CL) is now covered by analysts at BNP Paribas. They set an "outperform" rating and a $109.00 price target on the stock. This represents a 10.5% upside from the current price of $98.62.
  • Clorox (NYSE:CLX) is now covered by analysts at BNP Paribas. They set an "underperform" rating and a $130.00 price target on the stock. This represents a 5.6% downside from the current price of $137.68.
  • Envoy Medical (NASDAQ:COCH) is now covered by analysts at Ascendiant Capital Markets. They set a "buy" rating and a $8.50 price target on the stock. This represents a 222.0% upside from the current price of $2.64.
  • Cheniere Energy Partners (NYSE:CQP) is now covered by analysts at Sanford C. Bernstein. They set a "market perform" rating on the stock.The current price is $47.80.
  • Cognizant Technology Solutions (NASDAQ:CTSH) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $72.00 price target on the stock. This represents a 4.3% upside from the current price of $69.00.
  • Ekso Bionics (NASDAQ:EKSO) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $2.50 price target on the stock. This represents a 150.0% upside from the current price of $1.00.
  • Elevance Health (NYSE:ELV) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $643.00 price target on the stock. This represents a 19.2% upside from the current price of $539.23.
  • EPAM Systems (NYSE:EPAM) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $200.00 price target on the stock. This represents a 6.4% upside from the current price of $188.03.
  • Graham (NYSE:GHM) is now covered by analysts at Noble Financial. They set an "outperform" rating and a $35.00 price target on the stock. This represents a 24.6% upside from the current price of $28.09.
  • Globant (NYSE:GLOB) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $200.00 price target on the stock. This represents a 13.8% upside from the current price of $175.75.
  • Humana (NYSE:HUM) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $374.00 price target on the stock. This represents a 4.8% upside from the current price of $356.88.
  • International Business Machines (NYSE:IBM) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $200.00 price target on the stock. This represents a 13.1% upside from the current price of $176.88.
  • Keurig Dr Pepper (NASDAQ:KDP) is now covered by analysts at BNP Paribas. They set a "neutral" rating and a $36.00 price target on the stock. This represents a 4.9% upside from the current price of $34.31.
  • Kimberly-Clark (NYSE:KMB) is now covered by analysts at BNP Paribas. They set a "neutral" rating and a $146.00 price target on the stock. This represents a 4.0% upside from the current price of $140.39.
  • Coca-Cola (NYSE:KO) is now covered by analysts at BNP Paribas. They set an "outperform" rating and a $72.00 price target on the stock. This represents a 12.9% upside from the current price of $63.78.
  • Cheniere Energy (NYSE:LNG) is now covered by analysts at Sanford C. Bernstein. They set an "outperform" rating on the stock.The current price is $167.16.
  • Monster Beverage (NASDAQ:MNST) is now covered by analysts at BNP Paribas. They set an "underperform" rating and a $48.00 price target on the stock. This represents a 2.8% downside from the current price of $49.38.
  • PepsiCo (NASDAQ:PEP) is now covered by analysts at BNP Paribas. They set a "neutral" rating and a $174.00 price target on the stock. This represents a 3.5% upside from the current price of $168.12.
  • Procter & Gamble (NYSE:PG) is now covered by analysts at BNP Paribas. They set an "outperform" rating and a $187.00 price target on the stock. This represents a 10.8% upside from the current price of $168.73.
  • Playtika (NASDAQ:PLTK) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $8.50 price target on the stock. This represents a 7.2% upside from the current price of $7.93.
  • Praxis Precision Medicines (NASDAQ:PRAX) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $145.00 price target on the stock. This represents a 251.3% upside from the current price of $41.27.
  • Ryder System (NYSE:R) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $165.00 price target on the stock. This represents a 33.1% upside from the current price of $123.99.
  • Solventum (NYSE:SOLV) is now covered by analysts at Argus. They set a "hold" rating on the stock.The current price is $52.66.
  • TaskUs (NASDAQ:TASK) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $12.00 price target on the stock. This represents a 10.4% downside from the current price of $13.39.
  • Tectonic Therapeutic (NASDAQ:TECX) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.The current price is $16.48.
  • Thoughtworks (NASDAQ:TWKS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $2.50 price target on the stock. This represents a 8.1% downside from the current price of $2.72.
  • Vince (NYSE:VNCE) is now covered by analysts at Noble Financial. They set an "outperform" rating and a $3.00 price target on the stock. This represents a 114.3% upside from the current price of $1.40.
  • ZEEKR Intelligent Technology (NYSE:ZK) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $32.40 price target on the stock. This represents a 51.9% upside from the current price of $21.33.
  • View today's most recent analysts' new coverage at MarketBeat.com right arrow

Upgrade Your Subscription
Manage Your Watchlist
Join Our Facebook Group

Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
 
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
 
© 2006-2024 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.
 
Today's Bonus Content: How to build the ultimate dividend portfolio (Click to Opt-in)

No comments:

Post a Comment

🌎 The Week Ahead for 6/30/2024

Ratings changes for Illumina, Fortinet, Stratasys, TherapeuticsMD, Republic First Bancorp, Eagle Pharmaceuticals, Tenax Therapeutics and mor...